181 related articles for article (PubMed ID: 37504350)
1. Imaging Spectrum of the Developing Glioblastoma: A Cross-Sectional Observation Study.
Currie S; Fatania K; Frood R; Whitehead R; Start J; Lee MT; McDonald B; Rankeillor K; Roberts P; Chakrabarty A; Mathew RK; Murray L; Short S; Scarsbrook A
Curr Oncol; 2023 Jul; 30(7):6682-6698. PubMed ID: 37504350
[TBL] [Abstract][Full Text] [Related]
2. Radiological features of cerebellar glioblastoma.
Kikuchi K; Hiratsuka Y; Kohno S; Ohue S; Miki H; Mochizuki T
J Neuroradiol; 2016 Jul; 43(4):260-5. PubMed ID: 26740386
[TBL] [Abstract][Full Text] [Related]
3. Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.
Kim R; Choi SH; Yun TJ; Lee ST; Park CK; Kim TM; Kim JH; Park SW; Sohn CH; Park SH; Kim IH
Eur Radiol; 2017 Mar; 27(3):1176-1185. PubMed ID: 27357131
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of multiple brain metastases and glioblastoma with multiple foci using MRI criteria.
Müller SJ; Khadhraoui E; Ernst M; Rohde V; Schatlo B; Malinova V
BMC Med Imaging; 2024 Jan; 24(1):3. PubMed ID: 38166651
[TBL] [Abstract][Full Text] [Related]
5. Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings.
Ashdown BC; Tien RD; Felsberg GJ
AJR Am J Roentgenol; 1994 Jan; 162(1):155-9. PubMed ID: 8273655
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma.
Jo SW; Choi SH; Lee EJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Aug; 22(8):1369-1378. PubMed ID: 33987994
[TBL] [Abstract][Full Text] [Related]
7. Relationship between magnetic resonance imaging and molecular pathology in patients with glioblastoma multiforme.
Li WB; Tang K; Zhang W; Yan W; You G; Li SW; Zhang L; Huang YJ; Jiang T
Chin Med J (Engl); 2011 Sep; 124(17):2589-92. PubMed ID: 22040408
[TBL] [Abstract][Full Text] [Related]
8. Additional Diagnostic Value of Unenhanced Computed Tomography plus Diffusion-Weighted Imaging Combined with Routine Magnetic Resonance Imaging Findings of Early-Stage Gliblastoma.
Wang H; Liu Z; Zhang Y; Hou F; Fu W; Lin J; Liu Y; Liu X
Biomed Res Int; 2020; 2020():1672736. PubMed ID: 32149081
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions.
Kolakshyapati M; Hashizume A; Ochi K; Ueno H; Kaichi Y; Takayasu T; Takano M; Karlowee V; Akiyama Y; Awai K; Maruyama H; Sugiyama K; Kurisu K; Yamasaki F
World Neurosurg; 2019 Nov; 131():e226-e236. PubMed ID: 31349079
[TBL] [Abstract][Full Text] [Related]
10. Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme.
Li WB; Chen HY; Zhang W; Yan W; Shi R; Li SW; Jiang T
Chin Med J (Engl); 2013; 126(15):2881-5. PubMed ID: 23924460
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
Dhermain F
Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
[TBL] [Abstract][Full Text] [Related]
12. The Potential Role of Peritumoral Apparent Diffusion Coefficient Evaluation in Differentiating Glioblastoma and Solitary Metastatic Lesions of the Brain.
Tepe M; Saylisoy S; Toprak U; Inan I
Curr Med Imaging; 2021; 17(10):1200-1208. PubMed ID: 33726654
[TBL] [Abstract][Full Text] [Related]
13. MRI manifestions correlate with survival of glioblastoma multiforme patients.
Li WB; Tang K; Chen Q; Li S; Qiu XG; Li SW; Jiang T
Cancer Biol Med; 2012 Jun; 9(2):120-3. PubMed ID: 23691466
[TBL] [Abstract][Full Text] [Related]
14. Early stage glioblastoma: retrospective multicentric analysis of clinical and radiological features.
Ceravolo I; Barchetti G; Biraschi F; Gerace C; Pampana E; Pingi A; Stasolla A
Radiol Med; 2021 Nov; 126(11):1468-1476. PubMed ID: 34338949
[TBL] [Abstract][Full Text] [Related]
15. [F-DOPA PET/MR based target definiton in the 3D based radiotherapy treatment of glioblastoma multiforme patients. First Hungarian experiences].
Sipos D; Tóth Z; Lukács G; Bajzik G; Hadjiev J; Cselik Z; Repa I; Kovács Á
Ideggyogy Sz; 2019 May; 72(5-6):209-215. PubMed ID: 31241266
[TBL] [Abstract][Full Text] [Related]
16. Multicentric non-enhancing lesions in glioblastoma: A retrospective study.
Benouaich-Amiel A; Khasminsky V; Gal O; Weiss T; Fichman S; Kanner AA; Berkowitz S; Laviv Y; Mandel J; Dudnik E; Siegal T; Yust-Katz S
J Clin Neurosci; 2021 Mar; 85():20-26. PubMed ID: 33581785
[TBL] [Abstract][Full Text] [Related]
17. Radiological features of infantile glioblastoma and desmoplastic infantile tumors: British Columbia's Children's Hospital experience.
Bader A; Heran M; Dunham C; Steinbok P
J Neurosurg Pediatr; 2015 Aug; 16(2):119-25. PubMed ID: 25955808
[TBL] [Abstract][Full Text] [Related]
18.
Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
[TBL] [Abstract][Full Text] [Related]
19. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
[TBL] [Abstract][Full Text] [Related]
20. Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.
Toh CH; Castillo M
AJNR Am J Neuroradiol; 2017 Feb; 38(2):288-293. PubMed ID: 27856439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
